PRCT - PROCEPT BioRobotics Corporation News

Barclays Initiates Coverage On PROCEPT BioRobotics with Overweight Rating, Announces Price Target of

Barclays analyst Christopher Pasquale initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) wit

PROCEPT BioRobotics (NASDAQ: PRCT) Investors: Securities Class Action Filed; Shareholders Should Con

SAN DIEGO, Oct. 1, 2026 /PRNewswire/ -- The Shareholders Foundation, Inc. announced that a lawsuit h

LAWSUIT ALERT: Investors who lost money with PROCEPT BioRobotics Corporation (NASDAQ: PRCT) shares s

A lawsuit was filed for certain investors in PROCEPT BioRobotics Corporation shares. NASDAQ: PRCT in

defenseworld.net

PROCEPT BioRobotics (NASDAQ:PRCT) & Varex Imaging (NASDAQ:VREX) Critical Analysis

Varex Imaging (NASDAQ: VREX - Get Free Report) and PROCEPT BioRobotics (NASDAQ: PRCT - Get Free Repo

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioR

NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (PRCT) Investors to Take Immediate Action in t

New York, New York--(Newsfile Corp. - September 22, 2026) - Kaplan Fox & Kilsheimer LLP announces th

Portnoy Law Firm Announces Class Action on Behalf of PROCEPT BioRobotics Corporation Investors

LOS ANGELES, Sept. 22, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises PROCEPT BioRobotics Cor

PROCEPT BioRobotics Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Di

NEW YORK, Sept. 22, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action laws

Kaplan Fox Alerts PROCEPT BioRobotics Corporation (PRCT) Investors With Losses to a Securities Class

New York, New York--(Newsfile Corp. - September 21, 2026) - Kaplan Fox & Kilsheimer LLP announces th

PRCT Deadline: PRCT Investors with Losses in Excess of $100K Have Opportunity to Lead PROCEPT BioRob

NEW YORK, Sept. 21, 2026 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, rem

Deadline Alert: PROCEPT BioRobotics Corporation (PRCT) Shareholders Who Lost Money Urged To Contact

LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors

businesswire.com

PRCT Deadline: Rosen Law Firm Urges PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Stockholders with

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, reminds investors

PRCT FINAL DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 L

SAN FRANCISCO, Sept. 21, 2026 /PRNewswire/ -- Hagens Berman Sobol Shapiro LLP alerts investors in PR

Kaplan Fox Encourages PROCEPT BioRobotics Corporation (NASDAQ: PRCT) Investors Seeking Recovery to C

NEW YORK, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class acti

PRCT Investors Have Opportunity to Lead PROCEPT BioRobotics Corporation Securities Fraud Lawsuit wit

LOS ANGELES, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Schall, Brown & Schwartz LLP (“SBS”), a national sha

Long-Term Shareholders of PROCEPT BioRobotics Corporation (PRCT) Are Encouraged to Contact Johnson F

SAN DIEGO, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims

INVESTOR DEADLINE: PROCEPT BioRobotics Corporation (PRCT) Investors with Substantial Losses Have Opp

SAN FRANCISCO, Sept. 19, 2026 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP alerts investors i

PROCEPT DEADLINE: ROSEN, A RANKED AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation I

NEW YORK, Sept. 18, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,

businesswire.com

PROCEPT 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $1

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former

Kaplan Fox Alerts Investors of PROCEPT BioRobotics Corporation (PRCT) to a Federal Securities Class

New York, New York--(Newsfile Corp. - September 18, 2026) - Kaplan Fox & Kilsheimer LLP announces th

PRCT 4-DAY DEADLINE ALERT: PROCEPT BioRobotics Corporation Investors Alerted to September 22, 2026 L

San Francisco, California--(Newsfile Corp. - September 18, 2026) - Hagens Berman Sobol Shapiro LLP a

TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $28

TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lower

Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $25

Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overwei

Evercore ISI Group Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $23

Evercore ISI Group analyst Vijay Kumar maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Outperf

William Blair Downgrades PROCEPT BioRobotics to Market Perform

William Blair analyst Brandon Vazquez downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperfor

PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $397.424M Est

PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 millio

PROCEPT BioRobotics Q2 EPS $(0.47) Misses $(0.46) Estimate, Sales $94.498M Beat $92.893M Estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.47) per share which missed the an

Truist Securities Downgrades PROCEPT BioRobotics to Hold, Lowers Price Target to $25

Truist Securities analyst Richard Newitter downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Buy

This Nucor Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Wall Street analysts upgraded various top stocks, including Nucor, Varonis, Invitation Homes, and Ma

This Take-Two Interactive Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For

Wall Street analysts changed outlook on top names, see all changes on Benzinga's analyst ratings

Evercore ISI Group Initiates Coverage On PROCEPT BioRobotics with Outperform Rating, Announces Price

Evercore ISI Group analyst Vijay Kumar initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) wi

Top 3 Health Care Stocks You'll Regret Missing In Q2

Health care sector's oversold stocks present buying opportunity; RSI below 30 signals oversold,

This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday

Wall Street analysts changed outlook on top names like MKTX, PRCT, VOD, and JILL. See ratings page a

Leerink Partners Downgrades PROCEPT BioRobotics to Market Perform, Lowers Price Target to $29

Leerink Partners analyst Mike Kratky downgrades PROCEPT BioRobotics (NASDAQ:PRCT) from Outperform

PROCEPT BioRobotics Announces Two Milestones In Its WATER IV Prostate Cancer Clinical Program

PROCEPT BioRobotics (NASDAQ:PRCT) today announced two milestones in its WATER IV prostate cancer cli

Piper Sandler Reiterates Overweight on PROCEPT BioRobotics, Raises Price Target to $35

Piper Sandler analyst Matt O'Brien reiterates PROCEPT BioRobotics (NASDAQ:PRCT) with a Overwe

12 Health Care Stocks Moving In Thursday's Pre-Market Session

12 Health Care Stocks Moving In Wednesday's After-Market Session

PROCEPT BioRobotics Affirms FY2026 Sales Guidance of $390.000M-$410.000M vs $396.674M Est

PROCEPT BioRobotics (NASDAQ:PRCT) affirms FY2026 sales outlook from $390.000 million-$410.000 millio

PROCEPT BioRobotics Q1 EPS $(0.56), Inline, Sales $83.132M Beat $80.506M Estimate

PROCEPT BioRobotics (NASDAQ:PRCT) reported quarterly losses of $(0.56) per share which met the analy

Earnings Scheduled For April 29, 2026

Baird Initiates Coverage On PROCEPT BioRobotics with Neutral Rating, Announces Price Target of $30

Baird analyst David Rescott initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutra

12 Health Care Stocks Moving In Monday's After-Market Session

Truist Securities Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $30

Truist Securities analyst Richard Newitter maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy

Leerink Partners Maintains Outperform on PROCEPT BioRobotics, Lowers Price Target to $30

Leerink Partners analyst Mike Kratky maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Outperfor

TD Cowen Maintains Buy on PROCEPT BioRobotics, Lowers Price Target to $34

TD Cowen analyst Joshua Jennings maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy and lower

12 Health Care Stocks Moving In Thursday's Intraday Session

Piper Sandler Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $28

Piper Sandler analyst Matt O'Brien maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overwei

Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $34

Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight